Glycolysis-inhibiting tumor cell-derived microparticles to enhance immunogenic cell death for synergistic cancer immunotherapy
{{output}}
In situ vaccination represents a promising cancer immunotherapy strategy, yet its efficacy in solid tumors remains limited, primarily due to the immunosuppressive tumor microenvironment (TME) and resistance to immunogenic cell death (ICD)-inducing anti-tumor t... ...
